Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The relationships between normal and leukemic stem/progenitor cells are unclear. We show that in ∼80% of primary human CD34+ acute myeloid leukemia (AML), two expanded populations with hemopoietic progenitor immunophenotype coexist in most patients. Both populations have leukemic stem cell (LSC) activity and are hierarchically ordered; one LSC population gives rise to the other. Global gene expression profiling shows the LSC populations are molecularly distinct and resemble normal progenitors but not stem cells. The more mature LSC population most closely mirrors normal granulocyte-macrophage progenitors (GMP) and the immature LSC population a previously uncharacterized progenitor functionally similar to lymphoid-primed multipotential progenitors (LMPPs). This suggests that in most cases primary CD34+ AML is a progenitor disease where LSCs acquire abnormal self-renewal potential.

Original publication




Journal article


Cancer Cell

Publication Date





138 - 152


Adult, Aged, Aged, 80 and over, Animals, Antigens, CD, Antigens, CD34, Cell Differentiation, Cell Lineage, Gene Expression Profiling, Graft Survival, Granulocyte-Macrophage Progenitor Cells, Hematopoietic Stem Cells, Humans, Immunophenotyping, Leukemia, Myeloid, Acute, Leukocyte Common Antigens, Lymphoid Progenitor Cells, Mice, Mice, Inbred NOD, Mice, SCID, Middle Aged, Neoplastic Stem Cells, Transplantation, Heterologous, Young Adult